Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers
This project is creating a special collection of information and samples from patients with ovarian, fallopian tube, or peritoneal cancers. Think of it like a library for scientists. This library will contain blood and tissue samples, alongside important health details from each person. By bringing all this information together, researchers hope to learn more about how these cancers behave and why some treatments work better than others. The main aim is to improve our knowledge about these specific cancers. This could lead to new ways to spot the cancer earlier, understand how patients will respond to treatments, and find better ways to manage the disease if it comes back. Ultimately, this collection is designed to speed up the development of new and more effective treatments for these challenging cancers.
At a glance
What is this study about?
This project is creating a very important collection, like a master database. It brings together blood and tissue samples with detailed health information from people diagnosed with ovarian, fallopian tube, or peritoneal cancers. The main idea is to give scientists a rich resource to study these specific types of cancer in much more detail. By having access to actual patient samples and their health journeys, researchers can look for patterns and clues that might not be obvious otherwise.
The scientists plan to use this collection for several key areas of research. For example, they want to find out why certain treatments work well for some people but not for others. They'll also be looking for 'markers' in blood or tissue that can tell us how a cancer might behave or how well someone might respond to treatment. This could involve studying tiny cancer cells in the blood to help improve diagnoses and follow-up care.
Ultimately, the goal of this database is to speed up the discovery of new and better ways to fight these cancers. By understanding the disease better, researchers can develop new tests, more effective medicines, and potentially improve the chances of successful treatment for future patients. This kind of research is a crucial step towards finding breakthroughs.
Key takeaways
- Collecting vital samples and health info for ovarian, fallopian tube, and peritoneal cancers.
- Aims to improve understanding and discover new treatments.
- Participation involves no extra medication or hospital visits.
- Samples are taken during your usual tests and surgeries.
- Your contribution helps future patients with these cancers.
- You can withdraw at any time without impacting your care.
Who may be eligible?
To be part of this important database project, you need to be at least 18 years old. You must have been recently diagnosed with either ovarian cancer, fallopian tube cancer, or a type of cancer called primitive peritoneal cancer.
Another important requirement is that you are expected to have at least one surgery and chemotherapy as part of your treatment plan. Lastly, you'll need to give your full and written permission to join the study after understanding what it involves.
There are some reasons why you wouldn't be able to join. For example, if you are pregnant or breastfeeding, you wouldn't be eligible. Also, if your regular appointments and follow-up care would be difficult to manage due to personal circumstances, you might not be able to take part.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with ovarian, fallopian tube, or primitive peritoneal cancer?
- Are you expected to have surgery and chemotherapy?
- Are you able to give your informed and written consent to participate?
What does participation involve?
If you decide to take part, there's no extra treatment or medication involved. This project is all about collecting information and samples that are already part of your routine care for ovarian, fallopian tube, or peritoneal cancer. This means that during your regular hospital visits for diagnosis, surgery, and chemotherapy, some extra blood or tissue samples will be collected for this study, alongside your usual tests. Detailed health information from your medical records will also be added to the database. You won't have any additional hospital visits specifically for this study. The samples and data will be collected over the full period of your treatment and follow-up care, which will be ongoing as per your medical needs.
Potential risks and benefits
Locations (1)
- ICM - Institut régional du Cancer MontpellierVerified postcodeMontpellier, France· Recruiting
Common questions
What kind of information will be collected about me?
The study will collect blood samples, tissue samples from your surgery, and details about your health and treatments from your medical records.
Will I have to take any new medicines or treatments?
No, this study doesn't involve any new medicines or treatments. It's about collecting information and samples from your standard care.
How long will I be involved in this study?
Your involvement will be during your ongoing treatment and follow-up for your cancer, as your medical team recommends.
Will my personal details be kept private?
Yes, all your personal information and samples will be handled with strict privacy and coded so you can't be directly identified in the research data.
Why is this research important?
This research is important because it helps scientists learn more about these cancers, which can lead to better ways to diagnose, treat, and care for patients in the future.
How to find out more
Aurore MOUSSION
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.